Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19

BackgroundCOVID-19 pathology is associated with exuberant inflammation, vascular damage, and activation of coagulation. In addition, complement activation has been described and is linked to disease pathology. However, few studies have been conducted in cancer patients.ObjectiveThis study examined c...

Full description

Bibliographic Details
Main Authors:	Ellinor I. Peerschke, Alisa Valentino, Rachel J. So, Scott Shulman, Ravinder
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 cancer complement thromboinflammation endothelial dysfunction
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.716361/full

Similar Items

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
by: Phillip LR. Nicolson, et al.
Published: (2020-07-01)

Thromboinflammation and COVID-19: The Role of Exercise in the Prevention and Treatment
by: Helena Angelica Pereira Batatinha, et al.
Published: (2020-12-01)

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
by: Miklós Lipcsey, et al.
Published: (2021-02-01)

Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
by: Martina Schiavello, et al.
Published: (2023-01-01)

COVID-19 and renal involvement; evolving role of thromboinflammation, vascular and glomerular disease in the pathogenesis
by: Tella Sadighpour, et al.
Published: (2021-07-01)

Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022-11-01)

Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors
by: Wolfgang Siess, et al.
Published: (2020-11-01)

The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
by: Barry W. Festoff, et al.
Published: (2021-10-01)

Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
by: Cédric Garcia, et al.
Published: (2022-04-01)

Editorial: Complement and COVID-19 Disease
by: Zoltán Prohászka, et al.
Published: (2022-07-01)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
by: Julia S. Gauer, et al.
Published: (2022-10-01)

Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences
by: Remy Martins-Gonçalves, et al.
Published: (2023-01-01)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
by: Danyang Meng, et al.
Published: (2021-06-01)

Biomaterials for treating sepsis-induced thromboinflammation
by: Halle Lutz, et al.
Published: (2023-12-01)

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
by: E. L. Nasonov, et al.
Published: (2020-09-01)

Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium
by: Alexander Dupuy, et al.
Published: (2021-01-01)

Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved
by: Vikas Bhuria, et al.
Published: (2022-03-01)

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
by: Qing Zhang, et al.
Published: (2023-04-01)

Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
by: Phillip L. Marsh, et al.
Published: (2023-09-01)

Coagulation Profile of COVID-19 Patients
by: Georgia Kaiafa, et al.
Published: (2022-10-01)

In vitro evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell model
by: Alexandra Gerogianni, et al.
Published: (2023-04-01)

Corrigendum: Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
by: Phillip L. Marsh, et al.
Published: (2024-02-01)

Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation
by: Catarina Teixeira, et al.
Published: (2019-09-01)

The Role of Thromboinflammation in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
by: Devin W. McBride, et al.
Published: (2017-10-01)

Inhibition of SARS‐CoV‐2‐mediated thromboinflammation by CLEC2.Fc
by: Pei‐Shan Sung, et al.
Published: (2023-07-01)

COVID, complement, and the brain
by: Sonia I. Vlaicu, et al.
Published: (2023-07-01)

P2X1: a unique platelet receptor with a key role in thromboinflammation
by: Cécile Oury, et al.
Published: (2021-10-01)

Platelet-monocyte aggregates: molecular mediators of thromboinflammation
by: Christina C. Rolling, et al.
Published: (2023-05-01)

Platelet‐leukocyte interactions in COVID‐19: Contributions to hypercoagulability, inflammation, and disease severity
by: Eugenio D. Hottz, et al.
Published: (2022-03-01)

A 3-O-sulfated heparan sulfate dodecasaccharide (12-mer) suppresses thromboinflammation and attenuates early organ injury following trauma and hemorrhagic shock
by: Maria del Pilar Huby Vidaurre, et al.
Published: (2023-04-01)

Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
by: Ariunzaya Amgalan, et al.
Published: (2020-08-01)

Thromboinflammatory response is increased in pancreas transplant alone versus simultaneous pancreas-kidney transplantation and early pancreas graft thrombosis is associated with complement activation
by: Kristina Rydenfelt, et al.
Published: (2023-03-01)

Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms
by: E. V. Slukhanchuk, et al.
Published: (2022-09-01)

Complement Activation in Kidneys of Patients With COVID-19
by: Frederick Pfister, et al.
Published: (2021-01-01)

Experimental <i>Bothrops<i> </i>atrox</i> Envenomation: Blood Plasma Proteome Effects after Local Tissue Damage and Perspectives on Thromboinflammation
by: Joeliton S. Cavalcante, et al.
Published: (2022-09-01)

Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
by: Tatsuya Maruhashi, et al.
Published: (2021-05-01)

Thrombopoietin participates in platelet activation in COVID-19 patients
by: Enrico Lupia, et al.
Published: (2022-11-01)

Effects of the circulating environment of COVID-19 on platelet and neutrophil behavior
by: Alexander T. Fields, et al.
Published: (2023-03-01)

Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
by: Enrique Alfaro, et al.
Published: (2022-06-01)

Platelets and Immune Responses During Thromboinflammation
by: Matthias Mezger, et al.
Published: (2019-07-01)